Functional assays demonstrated that two miRNAs acted as tumor-suppressive miRNAs in BC cells by targeting cell-cycle-related genes (e.g., TRIP13, CCNB1, RAD51, PSPH, CENPN, KPNA2, and MXRA5) [14]. The gene discussed is RAD51; the disease is breast cancer.